Founded in May 2013 as a limited liability company in Delaware, Alector, Inc. is a clinical-stage biopharmaceutical company pioneering the field of immuno-neurology, a novel approach to treating neurodegenerative diseases. This innovative discipline targets immune dysfunction as a fundamental driver behind various neuropathologies that contribute to degenerative brain disorders. Alector is developing therapies designed to restore healthy immune function in the brain, aiming to simultaneously counteract multiple disease processes. For more information, visit their website at http://www.alector.com. Company Address: 131 Oyster Point Blvd, Suite 600 South San Francisco, California 94080

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for ALEC via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.